Yushi Feng

Dr. Feng joined Capricor in 2023 serving as the Vice President of Regulatory Affairs overseeing all global regulatory strategy for the DMD program as well as the exosome platform. Dr. Feng brings over 17 years of regulatory experience from both industry and the FDA, with an expansive career focusing on oncology, neurology, rare and infectious diseases as well as CMC (Chemistry Manufacturing and Controls) experience spanning multiple disciplines with extensive experience in manufacturing and quality systems.